Educating neurologists, using telehealth improves outcomes in Parkinson’s
By
Kristen Fischer
Nov 14, 2023
A new study looks at palliative care for people living with Parkinson’s disease and related disorders and found that educating neurologists and using telehealth is feasible to improve outcomes for people...
Adding rasagiline to treatment regimen may help those with Parkinson’s, study finds
By
Kristen Fischer
Oct 16, 2023
A recent study finds that the addition of rasagiline (marketed as Azilect) to the treatment regimen of individuals with Parkinson’s disease significantly enhances clinical outcomes.
Amyloid scans lower hospital visits — but not ED visits — in those with MCI, dementia
By
Kristen Fischer
Oct 11, 2023
A new study finds that using amyloid positron emission tomography scans can slightly reduce hospitalizations in people with mild cognitive impairment or dementia.
Loneliness linked to Parkinson’s disease development, researchers say
By
Kristen Fischer
Oct 03, 2023
A new study has linked loneliness to an increased risk for being diagnosed with Parkinson’s disease. The link was seen across different demographic groups, and it also existed despite risk factors like...
Study: Focusing on neurology — not just psychiatry — helps cut antipsychotic use in SNF residents
By
Kristen Fischer
Sep 29, 2023
A neurology-focused effort to reduce antipsychotic drugs in skilled nursing facilities lowered usage by 68% in people with behavioral and psychological symptoms of dementia, according to a new report published...
Study: 1 in 5 people on Medicare travel more than 50 miles to see neurologist
By
Kristen Fischer
Sep 14, 2023
Nearly 20% of people on Medicare have to travel 50 or more miles to see their neurologists — and that’s just one way. This means that people who receive care for neurological issues have to make quite...
Social isolation linked to dementia risk, lower brain volume
By
Alicia Lasek (f3)
Jun 09, 2022
Social isolation is tied to a 26% increased risk of dementia and loss of brain volume in areas linked to cognition, a long-term study finds.
Ethical considerations explored for aducanumab in Alzheimer disease
Nov 19, 2021
Grounds insufficient to offer aducanumab for moderate, advanced Alzheimer dementia or patients without biomarker evidence of brain ß-amyloid
DPP-4i use may protect in Alzheimer dementia with diabetes
Aug 12, 2021
Low amyloid burden and favorable cognitive outcomes seen with DPP-4i use in Alzheimer disease-related cognitive impairment with diabetes
Vitamins C and E linked to 32 percent lower risk of Parkinson’s in large study
By
Alicia Lasek
Jan 11, 2021
Investigators looked for a link between dietary antioxidants and Parkinson’s risk in more than 41,000 adults in a long-term Swedish public health study.